InflaRx (IFRX) Common Equity (2016 - 2026)
InflaRx (IFRX) posted Common Equity of $169.92 million for Q2 2026, down 100.0% from $64.57 trillion a year earlier but up 293.4% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, InflaRx's Common Equity came in at $46.95 million, down 28.5% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -12.7% (FY2020 to FY2025).
- In prior years, InflaRx's Common Equity was $65.63 million in FY2024 (-40.5%), $110.37 million in FY2023 (+22.4%), $90.14 million in FY2022 (-25.2%) and $120.44 million in FY2021 (+29.7%).
- Quarterly Common Equity has run from a low of $43.19 million in Q1 2026 to a high of $64.57 trillion in Q2 2025 over five years.
- On a year-over-year basis, Common Equity has declined in each of the last four quarters, with an average decline of 43.8% over the last seven quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2021, with growth of 29.7%; the weakest was Q2 2026, with a decline of 100.0%.
- According to Business Quant data, Common Equity for the three prior quarters was $43.19 million (Q1 2026), $48.37 million (Q4 2025) and $53.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.15 Bn | 1,101.73 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 616.41 Bn | 534.94 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.01 Bn | 474.12 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.15 Bn | 321.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.00 Bn | 261.99 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.56 Bn | 235.25 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.76 Bn | 116.40 Bn | 10.94 Bn | 85.49 Bn |
| 10 | InflaRx | 108.00 Mn | -225.62 Mn | 2.74 Mn | 166.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 166.97 Mn |
| Mar 31, 2026 | 42.28 Mn |
| Dec 31, 2025 | 48.82 Mn |
| Sep 30, 2025 | 53.22 Mn |
| Jun 30, 2025 | 66.90 Mn |
| Mar 31, 2025 | 76.27 Mn |
| Dec 31, 2024 | 63.91 Mn |
| Sep 30, 2024 | 72.92 Mn |
| Jun 30, 2024 | 87.98 Mn |
| Mar 31, 2024 | 102.29 Mn |
| Dec 31, 2023 | 113.54 Mn |
| Sep 30, 2023 | 124.63 Mn |
| Jun 30, 2023 | 135.47 Mn |
| Mar 31, 2023 | 85.69 Mn |
| Dec 31, 2022 | 94.19 Mn |
| Sep 30, 2022 | 97.74 Mn |
| Jun 30, 2022 | 106.69 Mn |
| Mar 31, 2022 | 106.17 Mn |
| Dec 31, 2021 | 119.23 Mn |
| Sep 30, 2021 | 133.68 Mn |
API Access
InflaRx Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();